TLX
Trans-Lux Corp.
NASDAQ · Healthcare · Biotechnology · AU
$9.57
+5.92%Margins
Gross margin
52.1%
EBITDA margin
3.5%
EBIT margin
-0.8%
Net margin
3.8%
FCF margin
-6.4%
6.9%
Return on equity
2.5%
Return on assets
-0.7%
Return on invested capital
0.70x
Asset turnover
-$11.8M
Cash from operations
$0.74
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026